Neil Harris Cohen serves as Executive at Chemomab Therapeutics Ltd., where they oversee executive responsibilities. Since joining the company, Neil Harris Cohen has executed 7 insider transactions totaling $152.2K, demonstrating a bullish approach to their equity position. Their most recent transaction on Nov 16, 2022 involved selling 2,409 shares valued at $4.8K.
Neil Harris Cohen currently holds 10,000 shares of Chemomab Therapeutics Ltd. (CMMB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Neil Harris Cohen has been a net buyer of CMMB stock. They have purchased $147.4K and sold $4.8K worth of shares.
Neil Harris Cohen's most recent insider trade was on Nov 16, 2022, when they sold 2,409 shares at $2.00 per share.
Get notified when new Form 4 filings are submitted
| $3.19 |
| Discretionary |
| Mar 14, 2022 | CMMB | $8.4K | Purchase | 2,000 | $4.20 | Discretionary |
| Mar 14, 2022 | CMMB | $8.6K | Purchase | 2,000 | $4.30 | Discretionary |
| Mar 14, 2022 | CMMB | $9.1K | Purchase | 2,000 | $4.56 | Discretionary |
| Dec 6, 2021 | CMMB | $14.9K | Purchase | 2,000 | $7.43 | Discretionary |
| Mar 16, 2021 | CMMB | $100.0K | Purchase | 2,409 | $41.51 | Discretionary |